Phase
Condition
N/ATreatment
ONO-4538
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Histological diagnosis of diffuse large B-cell lymphoma (DLBCL)-type or Hodgkinlymphoma(HL)-type Richter's transformation with a history of chronic lymphocyticleukemia (CLL) or small lymphocytic lymphoma (SLL)
In the case of DLBCL-type Richter's transformation, refractory, intolerant orineligible for treatment of DLBCL
Patients with measurable disease
Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
Expected to survive for 90 days or more
Exclusion
Exclusion Criteria:
Serious complications
Active multiple cancers
Active central nervous system (CNS) disease
History of allogeneic hematopoietic stem cell transplantation
Study Design
Connect with a study center
Aichi Cancer Center
Nagoya 1856057, Aichi-ken 1865694
JapanActive - Recruiting
Kyusyu University Hospital
Fukuoka 1863967, Fukuoka 1863958 812-8582
JapanActive - Recruiting
Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital
Hiroshima 1862415, Hiroshima 1862413
JapanActive - Recruiting
Hokkaido University Hospital
Sapporo, Hokkaido 060-8648
JapanSite Not Available
Hokkaido University Hospital
Sapporo 2128295, Hokkaido 2130037 060-8648
JapanActive - Recruiting
Kyoto University Hospital
Kyoto 1857910, Kyoto 1857907
JapanActive - Recruiting
Tohoku University Hospital
Sendai 2111149, Miyagi 2111888
JapanActive - Recruiting
Niigata University Medical & Dental Hospital
Niigata 1855431, Niigata 1855429
JapanActive - Recruiting
Kindai University Hospital
Ōsaka-sayama 11612568, Osaka 1853904
JapanActive - Recruiting
Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
Bunkyō-Ku, Tokyo 1850144
JapanActive - Recruiting
National Cancer Center Hospital
Chuo Ku, Tokyo 1850144
JapanActive - Recruiting
Kyusyu University Hospital
Fukuoka, 812-8582
JapanSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.